drugset / Trial / NCT05219266

Managed Access Programs for PKC412, Midostaurin

NCT05219266

Expanded access No longer available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to PKC4, Midostaurin.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Midostaurin Small molecule